Angeliki Ditsiou
Brighton, ENG BN19QG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
A Regulatory Element in the Intrinsically Disordered C-Terminal Region of LMTK3 Modulates Its Kinase Domain Interactions and Breast Cancer Phenotypes.
Journal: Cells
Published: June 25, 2026
Spleen tyrosine kinase (SYK) inhibition suppresses growth of gastrointestinal neuroendocrine tumor cells: a pilot study in two cell lines.
Journal: Cancer gene therapy
Published: September 01, 2025
FAK inhibition disrupts tumor growth, apoptosis, and transcriptional regulation in GI-NETs.
Journal: Endocrine oncology (Bristol, England)
Published: May 21, 2025
Kinome-Wide Synthetic Lethal Screen Identifies PANK4 as a Modulator of Temozolomide Resistance in Glioblastoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 24, 2023
The Inhibitory Properties of a Novel, Selective LMTK3 Kinase Inhibitor.
Journal: International journal of molecular sciences
Published: September 22, 2022
Diving into the dark kinome: lessons learned from LMTK3.
Journal: Cancer gene therapy
Published: October 06, 2021
The multifaceted role of lemur tyrosine kinase 3 in health and disease.
Journal: Open biology
Published: September 28, 2021
Correction to: LMTK3 inhibition affects microtubule Stability.
Journal: Molecular cancer
Published: April 10, 2021
The structure-function relationship of oncogenic LMTK3.
Journal: Science advances
Published: April 26, 2020
PIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progression.
Journal: The Journal of clinical investigation
Published: October 28, 2019
Last Updated: 09/26/2026